← board
SKVI
distress 6/10 · elevated risk$0.200%today-69% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
0.2 yrs
Shares 1y
0%
Price & events
-59.4% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
-9.1%
1W
-5.9%
1M
-19.4%
3M
-59.4%
6M
-12.2%
1Y
-71.0%
2Y
+42.9%
5Y
+185.7%
All
Overview
- Market Cap
- $1.08M
- Volume
- 0
- 52 Week Range
- $0.13 – $0.65
- Total Shares
- 5.40M
- Float Shares
- 5.21M
- % Held by Insiders
- 3.52%
- % Held by Institutions
- 0.00%
- Beta
- 1.71
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 5,403,843 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.